Organigram Global Inc. (OGI) Stock Price & Analysis
Organigram Global Inc. (OGI) — MoonshotScore 35/100 (Weak band), calculated Nov 18, 2026. Price $0.6296 (-6.95%), as of the Nov 19, 2026 trading session; market cap $88.9M.
Educational signal · not a buy or sell recommendation · How to read this
Organigram Global Inc. · OGI · NASDAQ
Organigram Global Inc. is a Canadian cannabis company focused on producing and selling a diverse range of cannabis and cannabis-derived products. They operate in both the medical and recreational markets, offering various brands and product formats.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Organigram Global (OGI)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Durable growth, at a cheap price, but a strained balance sheet. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and reported profit not backed by cash flow. Business Quality: Solid; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Growing; Momentum: Slipping.
- EPS beat 4 of the last 8 reports
- Altman Z 0.10 · Piotroski F 5
- ROE 22.0% · ROA 10.6% · current ratio 2.61 · earnings yield 54.3% · free-cash-flow yield -17.5%
Holding back: weak price trend
Helping: an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 34 | Weak | |
| 34 | Weak | |
| 34 | Weak | |
| 34 | Weak | |
| 35 | Weak | |
| 35 | Weak |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.6296 | |
| Change on the day | -6.95% | |
| Market capitalisation | $88.9M | — |
| Price / earnings (trailing) | 1.59 | |
| Shares traded on the day | 1.37M |
Price & events
Other perspectives
Council score for Organigram Global (OGI): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Organigram Global (OGI), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Organigram Global Inc. (OGI) is listed on NASDAQ. It employs 1,139 people. The market values it at $88.9M.
What do the latest results show for Organigram Global (OGI)?
Short answer · as of
Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Jun 2025 | C$71M | -C$6M | -C$0.05 (diluted) |
| Q4 FY2025 | C$80M | -C$38M | — |
| Q1 FY2026 | C$64M | C$20M | C$0.15 (diluted) |
| Q2 FY2026 | C$60M | -C$921,000 | -C$0.01 (diluted) |
What are the financial strengths and risks for Organigram Global (OGI)?
Short answer · as of
The MoonshotScore pillars rate an attractive price, durable growth as strengths. What is holding it back is weak price trend. The distress and quality screens read Altman Z 0.10 · Piotroski F 5. Trailing ratios: ROE 22.0% · ROA 10.6% · current ratio 2.61 · earnings yield 54.3% · free-cash-flow yield -17.5%.
Data-derived red flags
- Listing risk — at $0.6296 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
- Financial-distress signal — its Altman Z-Score of 0.10 sits in the distress zone (elevated bankruptcy risk).
How does Organigram Global compare with its peers?
Short answer
Organigram Global's score ranks 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $6.57 Nov 18, 2026 | $98.5M | 51 5-pillar Nov 18, 2026 | |
| $0.88 Nov 19, 2026 | $113M | 49 5-pillar Nov 18, 2026 | |
| $2.65 Nov 19, 2026 | $190M | 38 5-pillar Nov 18, 2026 | |
| Organigram Global (OGI) — this page | $0.6296 | $88.9M | 35 |
| $1.50 Nov 18, 2026 | $71.1M | 32 5-pillar Nov 18, 2026 | |
| $1.24 Nov 19, 2026 | $302M | 32 5-pillar Nov 18, 2026 | |
| $3.55 Nov 19, 2026 | $100M | 31 5-pillar Nov 18, 2026 | |
| $0.74 Nov 19, 2026 | $38.4M | 31 5-pillar Nov 18, 2026 | |
| $0.85 Nov 18, 2026 | $111M | 28 5-pillar Nov 18, 2026 | |
| $2.66 Nov 18, 2026 | $28.9M | 25 5-pillar Nov 18, 2026 | |
| $5.15 Nov 19, 2026 | $265M | 24 5-pillar Nov 18, 2026 | |
| $2.60 Nov 19, 2026 | $25.9M | 23 5-pillar Nov 18, 2026 | |
| $6.37 Nov 19, 2026 | $241M | 21 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held OGI in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported OGI in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Organigram Global (OGI)?
What Investors Ask About Organigram Global (OGI)
These answers are editorial: 1 of these 9 answers is drawn from the OGI research dossier (written May 5, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for OGI?
OGI carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is OGI a good stock to buy?
Stock Expert AI does not rate OGI buy, sell or hold. Organigram Global Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the OGI stock price today?
The last price recorded for Organigram Global Inc. (OGI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Organigram Global Inc. do?
Organigram Global Inc. is a Canadian cannabis company that cultivates, produces, and sells a range of cannabis and cannabis-derived products. These products include dried flower, oils, edibles, and concentrates, catering to both the medical and recreational markets.
What are the key factors to evaluate for OGI?
Organigram Global Inc. (OGI) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. Not financial advice.
How frequently does OGI data refresh on this page?
OGI's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven OGI's recent stock price performance?
Organigram Global Inc. (OGI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider OGI overvalued or undervalued right now?
The trailing P/E of Organigram Global Inc. (OGI) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of OGI?
Fractional-share availability for Organigram Global Inc. (OGI) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 5, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 11 figures on this page — 6 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com